Growth-inhibitory effect of a streptococcal antitumor glycoprotein on human epidermoid carcinoma A431 cells: Involvement of dephosphorylation of epidermal growth factor receptor

Cancer Research

Volumn 61, Issue 16, 2001, Pages 6151-6157

  Yoshida, J ^a   Ishibashi, T ^a   Nishio, M ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOPROTEIN; STREPTOCOCCAL ACIDIC GLYCOPROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPHOSPHORYLATION; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STREPTOCOCCUS PYOGENES;

ANTIBIOTICS, ANTINEOPLASTIC; BACTERIAL PROTEINS; CARCINOMA, SQUAMOUS CELL; CATALASE; CELL DIVISION; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; GLYCOPROTEINS; GROWTH INHIBITORS; GTP-BINDING PROTEINS; HUMANS; MAP KINASE SIGNALING SYSTEM; PERTUSSIS TOXIN; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED; TYROSINE; VANADATES; VIRULENCE FACTORS, BORDETELLA;

EID: 0035881571     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Streptolysin s-forming and antitumor activities of group A streptococci
2. Purification and characterization of an antitumor principle from Streptococcus hemolyticus (Su strain)
3. Characterization of a streptococcal antitumor glycoprotein (SAGP)
4. Antitumor action of an acidic glycoprotein (SAGP) from Streptococcus pyogenes in mice
5. A simplified method for purification of an antitumor acidic glycoprotein from Streptococcus pyogenes (Su strain) by immuno-absorbent chromatography
6. Evidence for the involvement of sulfhydryl groups in the expression of antitumor activity of streptococcal acid glycoprotein (SAGP) purified from crude extract of Streptococcus pyogenes
7. Streptococcal glycoprotein-induced tumour cell growth inhibition involves the modulation of a pertussis toxin-sensitive G protein
8. Antiproliferative and apoptosis-inducing effects of an antitumor glycoprotein from Streptococcus pyogenes
9. G protein activation of a hormone-stimulated phosphatase in human tumor cells
10. The somatostatin receptor SSTR I is coupled to phosphotyrosine phosphatase activity in CHO-KI cells
11. Effect of tumor necrosis factor-α on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases
12. M3: Involvement of receptor-directed protein tyrosine phosphatase(s)
13. sst2 somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase SHP-I
14. Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells
15. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation
16. Syp (SH-PTP2) is a positive mediator of growth-factor stimulated mitogenic signal transduction
17. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation
18. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor
19. Octapeptide somatostatin analog SMS 201-995 induces translocation of intracellular PTPIC to membranes in MCF-7 human breast adenocarcinoma cells
20. The transmembrane protein tyrosine phosphatase RPTPσ modulates signaling of the epidermal growth factor receptor in A431 cells
21. Tumor necrosis factor employs a protein-tyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factor-induced endothelial cell proliferation
22. Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases
23. Protein tyrosine phosphatase 1B interacts with and is tyrosine phosphorylated by the epidermal growth factor receptor
24. Association of SH2 domain protein tyrosine phosphatases with the epidermal growth factor receptor in human tumor cells. Phosphatidic acid activates receptor dephosphorylation by PTP1C
25. Both SH2 domains are involved in interaction of SHP-1 with the epidermal growth factor receptor but cannot confer receptor-directed activity to SHP-1/SHP-2 chimera
26. Coupling of the murine protein tyrosine phosphatase PEST to the epidermal growth factor (EGF) receptor through a Src homology 3 (SH3) domain-mediated association with Grb2
27. The transmembrane protein-tyrosine phosphatase CD45 is associated with decreased insulin receptor signaling
28. Multiple cytokines induce the tyrosine phosphorylation of Shc and its association with Grb2 in hemopoietic cells
29. The adaptor protein Shc interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation
30. Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro
31. Multiple actions of somatostatin in neoplastic disease
32. Somatostatin analogs: Future directions
33. A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity
34. Molecular biology of somatostatin receptor subtypes
35. Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cells
36. The tyrosine phosphatase SHP-I associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling
37. 1 cell cycle arrest
38. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: A primary role for tyrosine phosphatase SHP-1
39. Induction of a negative autocrine loop by expression of sst2 somatostatin receptor in NIH 3T3 cells
40. Phosphatase inhibitors modulate the growth-regulatory effects of human tumor necrosis factor on tumor and normal cells
41. Differential expression and translocation of protein tyrosine phosphatase 1B-related proteins in ME-180 tumor cells expressing apoptotic sensitivity and resistance to tumor necrosis factor: Potential interaction with epidermal growth factor receptor